Investigational New Drugs · 2005 · 105 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyMetastasisNeoplasiaMalignant NeoplasmsMelanocytic TumorsMelanoma PharmacotherapyMetastatic Disease TreatmentSystemic Therapy For Skin CancerMalignant Melanocytic TumorsMelanoma ProgressionMetastatic Melanoma TreatmentPhase Ii InvestigationStudy Phase
16
Michael B. Atkins, Lori Kunkel, Mario Sznol et al. · PubMed · 2000 · 518 citations
Medicine, Immunology, Oncology +11
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.
Sudhir B. Kondapaka, Sheo S. Singh, Girija Dasmahapatra et al. · PubMed · 2003 · 405 citations
Medicine, Oncology, Pharmacology +17
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Jiřina Bártková, Jiří Lukáš, Per Guldberg et al. · PubMed · 1996 · 276 citations